Hyperprolactinemia and autoimmune diseases
Clicks: 314
ID: 121362
2007
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
70.4
/100
314 views
207 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #6 of 8 articles by views in autoimmunity reviews
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The autoimmune diseases are more common in females. The sex hormones have an important role in this gender bias, mainly estrogen and prolactin (PRL) which modulate the immune response. PRL is secreted from the pituitary gland and other organs and cells mainly the lymphocytes. PRL has an immunostimul …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (48 words).
Try re-searching for a better abstract.
| Reference Key |
h2007autoimmunityhyperprolactinemia
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Orbach H;Shoenfeld Y;; |
| Journal | autoimmunity reviews |
| Year | 2007 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
hedi orbach
autoimmune diseases / immunology
yehuda shoenfeld
hyperprolactinemia / immunology*
pmid:17854745
doi:10.1016/j.autrev.2006.10.005
autoimmune diseases / blood*
hyperprolactinemia / genetics
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.